Borders Lowers 2004 Guidance; Fairly Upbeat For 2005

February 2005
Book Publishing Report;2/14/2005, Vol. 30 Issue 6, p1
Trade Publication
The article focuses on Borders Group Inc. that has cut its full-year earnings guidance for 2004, now expecting earnings to be $1.68 to $1.69 a share instead of its previously anticipated $1.69 to $1.72 per share. The company will release its full 2004 and fourth quarter revenues at market close March 10, but said its unaudited revenues for fiscal 2004, ended January 23, rose 4.9% to reach $3.88 billion. Earnings for the fourth quarter of fiscal 2004 exceed expectations, with comparable store sales for books rising 2% for the quarter.


Related Articles

  • NRC shows continued financial growth but it is not from membership.  // Resource Recycling;Mar2006, Vol. 25 Issue 3, p68 

    The article reports on the financial statements for the 2004-2005 fiscal year, and for the third year in a row posted a surplus, released by National Recycling Coalition (NRC) in Washington. The overall revenue totaled 1.52 million dollars during this period, with much of their funding coming...

  • Restatement accounting. Green, David L.B. // Accountancy;Aug1977, Vol. 88 Issue 1008, p54 

    This article discusses the concept of restatement accounting. There are steps required to prepare a set of restatement accounts. Firstly, a current cost account balance sheet is prepared made up to the latest date. This balance sheet is set along side the CCA balance sheets for previous years in...

  • 2Q Earnings Report Lifts TNS Shares.  // American Banker;8/8/2007, Vol. 172 Issue 152, p11 

    The author reports that TNS Inc. reported earnings for the second quarter of 2007 of 22 cents a share. According to the article, these earnings exceeded the predictions by eight cents a share. This earning report led to a rise in stock prices and changed the earnings forecast to 91 cents a share...

  • PURE BIOSCIENCE HAS 3RD QTR FISCAL NET LOSS OF $2,466,400.  // Biotech Financial Reports;Jul2008, Vol. 15 Issue 7, p7 

    The article reports on the financial statement of Pure Bioscience's revenues for the 2008 third fiscal quarter. The financial statement showed that Pure Bioscience's net loss for 2008 is $2,466,400 or 0.09 per share. It also demonstrated that the company's net losses for the 2008 fiscal year...

  • ABA Treasurer's Report 2005-2006.  // ABA Journal;Mar2006, Vol. 92 Issue 3, p65 

    The article presents the treasurer's report of the American Bar Association for the fiscal year ended August 31, 2005. Total association revenue for 2004 and 2005 of $191 million is composed primarily of general operations, section activities, gifts & grants and the James O. Broadhead...

  • The Commonwealth Government Is spending $1.75 for every dollar it receives, excluding federal grants. Márquez, Carlos // Caribbean Business;6/16/2005, Vol. 33 Issue 23, p16 

    Presents a discussion on the state of finances of the Commonwealth of Puerto Rico for the fiscal year ended June 30, 2004. Figures in the Comprehensive Annual Financial Report (CAFR); Component units of the Commonwealth; Expense net of program revenue; General fund deficit; Capital assets;...

  • Games strong, films weak in solid Sony third quarter. Blair, Gavin J.; Szalai, Georg // Hollywood Reporter -- International Edition;2/1/2008, Vol. 403 Issue 19, p102 

    The article focuses on the financial statements of Sony Corp., for fiscal third-quarter, as reported on January 31, 2008. The company's profits increased by 25% due to the earnings from its electronics unit and the first profit from its video gaming division in six quarters. Sony reported a...

  • Solazyme Reports 4th Qtr and FY 2011 Results.  // Biomedical Market Newsletter;2/21/2012, Vol. 21, p1 

    The article informs that Solazyme Inc. has released its financial results for the fourth quarter and full year (FY) ended December 31, 2011 along with corporate highlights. It indicates that total revenue for the fourth quarter was 14.9 million dollars compared with 23.2 million dollars in the...

  • Targacept Reports 4th Qtr and 2011 Financial Results.  // Biomedical Market Newsletter;2/21/2012, Vol. 21, p1 

    The article informs that Targacept Inc. has released its financial results for the fourth quarter and full year (FY) ended December 31, 2011. It indicates that the company has reported a net loss of 9.8 million dollars for the fourth quarter of 2011, compared to a net loss of 2.2 million dollars...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics